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Complement pattern in membranoprolipherative glomerulone-
phritis (MPGN). A. Anelli, A. Costantino, G. Montagnino, A.
DeVecchi, A. Tarantino. Divisione di Nefrologia e Dialisi, Os-
pedale Policlinico, Milano, Italy. Serum CH5O, Clq, Cis, C4,
C3, C5, C9, and C3PA levels were determined in 212 serum sam-
ples from 39 patients with MPGN. Serum nephritic factor (NeF)
was found in 5 out of 9 patients with type II (DD) MPGN and in I
out of 30 patients with type I (SD) MPGN. CH5O, C3, and C5
levels were reduced in both groups as compared to 48 healthy
controls. Four different complement patterns were present in se-
rial determinations performed in patients with SD-MPGN: (1) in
11 patients complement levels were increased as compared to
normal; (2) in 13 patients Clq, Cis, C4, C3, and CS levels were
significantly reduced; (3) in 2 patients Clq, Cis, C3, CS, and C9
were low, whereas C4 was in the normal range; (4) in 4 patients
significantly low C3 levels were observed. In patients with DD-
MPGN, C3, C5, and C3PA were lower than normal, but C3PA
levels were reduced only in NeF-positive patients. Conclusion.
These patterns of serum complement could imply various patho-
genetic mechanisms in MPGN.
Use of thiazide in the prevention of hypercalciuria in recurrent
stone-formers (HRSF): Clinical and metabolic evaluation. A.
Aroldi, A. Antonacci, G. Bonforte, M. Surian, E. Macchi,
A. Cantaluppi, and G. Graziani. Divisione di Nefrologia e Dial-
isi, Ospedale Policlinico, and Ca' Granda Niguarda, Milano,
Italy. Clinical and metabolic effects of long-term thiazide therapy
were evaluated in 64 patients with HRSF: 34 with calcium renal
leak, 18 with intestinal hyperabsorption, and 12 with primary
phosphate leak. These 64 patients passed 576 stones in the 2304
months before treatment with a patient-risk of I stone every 4
months, whereas during the 689 months of therapy this risk
dropped to 1 stone every 172 months (P 0.001). One month
after the beginning of therapy, in the renal group, the fasting CaE
decreased from 0.16 0.05 to 0.09 0.03 (P = 0.001); in the
intestinal group, both before and after food intake, the CaE fell
from 0.18 0.06 to 0.10 0.05 (P = 0.001). The Tm0,/GFR
decreased from 2.9 0.4 to 2.0 0.6 (P = 0.001) in the renal
group, and from 3.2 0.2 to 2.3 0.5 (P = 0.001) in the in-
testinal group. Transient weakness and hypotension (8 cases)
were observed; other side effects were hyperuricemia (25 cases)
which could be normalized giving allopurinol, impotence (4 cas-
es), and hyperglicemia (1 case). A parathyroid adenoma was dis-
covered in 4 patients who developed severe hypercalcemia. Con-
clusion. Thiazide reduces the incidence of stones and seems to
correct or underline some metabolic disorders in hypercalciuric
recurrent stone-former patients.
Urinary angiotensin-converting enzyme activity In pyelonephri-
tis. B. Baggio, S. Favaro, A. Piccoli, D. Ivlontanaro, A. Anto-
nello, U. Fagiolo, A. Borsatti, and E. Fiaschi. Istituto di Clinica
Medica I, Padova, Italy. Angiotensin-converting enzyme (ACE)
is located in the brush border of kidney tubules. Owing to this
localization and the high molecular weight of the enzyme, uri-
nary ACE activity should represent a good index of tubular dam-
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age. Urinary ACE activity has been evaluated in 5 groups: 30
controls, 21 with pyelonephritis, 21 with glomerulonephritis, 9
with cystitis, and 7 with hypertensive disease. The mean (± SEM)
values were 33.23 37.2 moles His-Gly/g creatinine in con-
trols, 277.94 37.2 in pyelonephritis, 57.97 17.8 in cystitis,
and 57.34 10.9 in hypertensive disease. An analysis of variance
showed that urinary ACE activity was significantly higher than
normal only in pyelonephritic patients (F = 26.5; P = 0.005).
According to these data, urinary ACE activity seems to be a
good index of renal tubular damage.
Hepato-renal syndrome: Renal function prior and after pharma-
cologic denervation of kidney during acute portal hypertension. G.
Bazzato, J. S. Gordon, S. Landini, S. Lucatello, M. Morac-
chiello, A. Saggioro, G. Galletti, U. Coli. Servizio di Nefrologia
e Dialisi; Osp. Umberto J0 Ivlestre; Istituto di Chirurgia Speri-
mentale, Bologna. Acute portal vein constriction in anesthetized
dogs and pigs resulted immediately in a slight decrease in blood
pressure (8%) and renal blood flow (RBF) (15%), and GFR was
markedly reduced (41%), likewise urine volume (U) (57%) and
sodium excretion (UN) (44%). Expansion of blood volume by
normal saline or Dextran-40 produced immediate return of BP
and RBF to control levels, but GFR, U, and UNA did not improve.
Infusion of pitressin (0.4 pressor units/mm) in the superior mes-
enteric artery during portal constriction resulted in a progressive
decrease in portal pressure, associated with a parallel increase in
GFR and U over a 30-mirt period. From this study we postulated
the existence of a splanchnic reflex affecting renal function by
suppressing GFR. To elucidate the exact role of such a reflex
during portal constriction, one kidney was pharmacologically de-
nervated by injection of xylocaine into the vascular pole. Where-
as the intact kidney showed a typical hemodynamic pattern with
decrease of RBF, U, and UNa, the controlateral denervated one
exhibited unchanged behavior over the same period. Subsequent
denervation of the controlateral kidney was followed by the re-
turn of RBF and urinary parameters to the preconstriction level.
Plasma 25-OH on CC kinetics after oral loading of vit. D in
anephric patients. D. Brancaccio, G. Coen, C. Galnmozzi, S. Ca-
sari, N. Case, E. Rivolta, G. Lucentini, and G. Bianchini. Divi-
sione di Nefrologia, Policlinico di Milano, Clinica Medica 2, Po-
liclinico di Roma, Italy. Uremic osteodystrophy is commonly at-
tributed to a lack of 1-alpha renal activation of vit. D; yet a few
AA reported the key role of 25-OH CC deficiency in the genesis
of the osteomalacic component of this complex uremic bone dis-
ease. To evaluate the hepatic behavior of patients on routine dial-
ysis therapy (RDT), plasma 25-OH CC kinetics have been stud-
ied in 4 anephric patients in comparison with 4 nonanephric pa-
tients on RDT. Colecalciferol (100,000 IU) was administered
orally for 4 weeks, and plasma levels of 25-OH CC, Ca, P. and
alk. phosphatase were monitored weekly. The anephric patients
showed higher basal levels of 25-OH CC (89.9 g/ml) than the
nonanephric control patients on RDT (36.5 33.4 sg/ml). Dur-
ing the administration of vit. D, the anephric patients showed
higher levels of increase in 25-OH CC (+ 132% after 7 days) than
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the control patients, and similarly higher levels of plasma cal-
cium. Our results show that anephric patients seem to be rather
sensitive to the vit. D therapy and confirm our previous observa-
tions of a lower degree of their osteomalacia.
Relationship between immune complexe (IC) and polymorpho-
nuclear (PMN) in vivo interaction test and in serum IC detection
(SP-Clq method). C. Camussi, C. Segoloni, R. Coppo, M. Mess-
ma, C. Cottura, and R. Genovesio. Cattedra di Nefrologia, Os-
pedale Maggiore S. Giovanni Battista, Turin, Italy. It has been
shown that human polymorphonuclear neutrophils (PMN) have
receptor for the FC fragment of immune complexes (IC) and for
C3b complement fraction. The PMN-IC interaction results in
phagocytosis of IC's with subsequent lysosomal components re-
lease. A simple immunohistologic test has been developed to de-
tect and to quantify the presence of IC on the surface of human
PMN. In this report, we compare the in vivo IC-PMN interaction
test with the detection of IC's in serum by SP-Clq method, in
several human IC diseases. High amounts of immunoglobulins
(Ig) and C3 were detected on the surface of PMN from these
patients. The spots" of Ig and C3 on PMN were inversely re-
lated to the percentage of membrane-free receptors for FC and
C3b, and directly related to the inhibition of phagocitosis. Fur-
thermore in vivo FC-PMN interaction test appears to be highly
sensitive and is often better related to the clinical course than
serum IC detection. Our results indicate that PMN can be used in
a simple, rapid immunohistologic test to detect the presence of
circulating IC's.
Hypersensitivity to iodine-containing radio-opaque media dur-
ing intravenous pyelogram: Clinical usefulness of the basophil
degranulation test. G. Camussi, P. Stratta, P. Mairano, D.
Bosio, and A. Vercellone. Cattedra di Nefrologia Medica
dell'Universith di Torino, Divisioni di Nefrologia e Dialisi del
l'Ospedale Maggiore di S. Giovanni Battista e della citth di To-
rino. The degranulation of IgE-sensitized circulating basophils
and tissue mastocytes leading to the release of several mediators
of anaphylaxis is responsible for hypersensitivity-related phe-
nomena. An overall study of the allergic state comprises the fol-
lowing: the synthesis of specific IgE, their fixation on cellular
receptor, and the degranulation of basophils and mastocytes in
the presence of the specific antigen. A simple one-step rapid
method for the detection of IgE-sensitized basophil degranula-
tion in the presence of specific antigens has been previously de-
scribed in experimental and human pathology. We studied 35 pa-
tients, among whom 23 had experienced some allergic reaction
during previous contrastographic X-ray studies. The degranula-
tion test was performed in the presence of several iodine-con-
taining compounds of different composition. All the patients with
a history of allergic reactions showed an in vitro clear-cut baso-
phil degranulation to the compound used in the previous intra-
venous pyelogram. On the contrary, when no degranulation
could be detected, patients underwent intravenous pyelogram
with no allergic reaction whatsoever. The degranulation test use-
fully allowed the clinician to prevent any allergic reaction and to
choose the most suitable contrast medium for his patient.
Plasma catecholamines and blood pressure during hemo-dialysis
or diafiltration. G. Cannella, G. B. Picotti, L. Cristinelli, and
R. Maiorca. Department of Nephrology, Spedali Civili, Brescia,
and Dept. Pharmacology, School of Medicine, University of Mi-
lan, italy. The changes in plasma catecholamine concentrations
during body fluid removal by dialysis (H) and ultrafiltration (DF)
have been evaluated in 7 uremic patients with frequent intra-
dialytic hypotension and related to the changes in blood pressure
(BP). The patients underwent H for 3 hours and 3 days later an
equivalent period of DF. Body weight (BW), pulse rate, and BP
were recorded every 10 mm. Forearm arterial blood samples for
the radioenzymatic assay of plasma noradrenaline (NA) and ad-
renaline (A) were collected every 20 mm. Blood samples for the
estimation of the clearances of plasma NA and A in the dialyzer
were taken every 60 mm. During H, BP constantly fell (signifi-
cantly after 60 mm) together with BW, whereas during DF it de-
creased significantly only after 150 mm. Both during H and DF,
pulse rate changes were inversely related to the changes in BP.
Plasma NA increased both during H and DF, the increases being
significant after 80 and 150 mm for H and DF, respectively. The
changes in plasma NA levels so appeared to be inversely related
to the changes in BP and directly related to those of pulse rate.
Plasma A was slightly but not significantly increased during H
only. The clearances of NA and A were significantly higher dur-
ing H than DF. The present findings indicate that the better
homeostatic control of BP during DF than during H is not merely
associated with higher levels of plasma NA in the former condi-
tion. The increased activity of sympathetic vasoconstrictor
nerves, which is reflected by the increases in circulating NA lev-
els, appears to be inversely related to the blood pressure de-
crease. Moreover, it seems to be inadequate during H to main-
tain BP levels. During H, an elevated NA clearance might inter-
fere with the sympathetic response to the circulatory stress.
Long-term prognosis in 528 patients with primary chronic gb-
merulonephritis. G. Colsanti, E. Imbasciati, G. Barbiano di Bel-
gioioso, M. Surian, F. Ferrario, R. Damasso, L. Radaelli, and
L. Guerra. Divisions of Nephrology, San Carlo, Policlinico and
Ca Granda Hospitals, Milan, Italy. Long-term prognosis has
been evaluated after an average follow-up period of 6 5 years
in 528 patients (214 males) with a mean age of 33 13 years (428
l2-year-olds) classified by means of light and immunofluorescent
microscopy as membranous glomerulonephritis (MGN, 118
cases), membranoproliferative glomerulonephritis (MPGN, 110
cases), focal glomerulosclerosis (FGS, 98 cases), and IgA-mes-
angial deposits glomerulonephritis (IgAGN, 202 cases). The ac-
turial survival rates showed that 12% of IgAGN patients, 20% of
FGS patients, 44% of MGN patients, and 50% of MPGN patients
died or went on hemodialysis by the 10th year. The progression
rate from initial renal failure (IRF) to terminal uremia was not
different in the four types of glomerulonephritis. The following
parameters were significantly correlated with an unfavourable
outcome: (I) the male sex in MPGN; (2) the occurrence of a
nephrotic syndrome and the presence of C3 deposits in MGN
and FGS; (3) the presence of proteinura, 2 glday in IgAGN; (4)
the early observation (preceding IRF) of glomerular obsoles-
cence in more than 30% of glomeruli in all the four types of gb-
merulonephritis. No significant effect of adequate immunode-
pressive therapy on the outcome of these four types of gbomeru-
lonephritis could be demonstrated.
Correlations between complement breakdown products and im-
mune complexes in plasma from patients with glomerulonephritis.
R. Coppo, M. Dc March, S. Alloatti, S. Segoloni, F. Quarello,
F. Giacchino, and C. Piccoli. Nephrology Units S. Giovanni
Hospital, and University of Turin, Italy. Institute of Human Ge-
netics. An approach to the dynamic evaluation of the com-
plement has been recently provided by the detection of the com-
plement breakdown products, C3d and Ba, increased when the
complement system is activated. The measurement of the C3
(beta-lA) provided by the commercial plates gives less precise
information than the measurement of single component break-
down products, and an increased rate of synthesis can mask an
increased catabolism of complement factors. We present a study
on 35 cases of glomerulonephritis byoptically investigated: the
sera from these patients were tested for C3d and Ba, and for C3
(beta-IA), C4, and factor B, and correlated with the level of cir-
culating immune complexes detected by the Clq solid phase test,
modified in enzyme-linked immunosorbent assay (ELISA). A
significant correlation was observed between decreased levels of
C3 (beta-lA) and increased amounts of C3d, but it is not uncom-
mon to find increased levels of complement breakdown prod-
ucts, in spite of normal values of C3 and factor B. Sera positive
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for circulating immune complexes with Clq solid phase ELISA
showed frequently high levels of C3d, whereas increased
amounts of Ba may be found even in the absence of circulating
immune complexes, probably because of the activation via the
alternative pathway other than by immune complexes.
Is essential hypertension caused by a primary kidney abnormal-
ity? D. Cusi, C. Barlassina, Bracchi, Picotti, M. Gatti, P. Lupi,
P. Ferrari, D. Gori, L. Ronzoni, 0. Velis, and G. Bianchi. 1st
Clinica Medica r e Scuola di Spec. Nefrologia Medico, Univ.
Milano, Italy. As kidney function and blood pressure may affect
each other, a primary kidney involvement in the pathogenesis of
essential hypertension should be evaluated before the develop-
ment of hypertension. We have studied 56 young normotensive
subjects with a highly positive familiarity for essential hyper-
tension (and so prone to develop hypertension later in life) and 35
subjects with negative familiality. The subjects were perfectly
matched for age (14 to 35 years), sex, body weight, height.
Plasma and urinary electrolytes and protein, inulin and creati-
nine clearances, urinary aldosterone, plasma volume, plasma
catecholamines, and cardiac index were equal in the two groups.
Blood pressure was slightly higher in the first group (128 1.6
and 123 2.1 [P = 0.1]vs. 81.9 1.1 and 78.2 l.4[P = 0.05]
[mean SEM]), also if all the subjects were considered normo-
tensive according to W. H. 0. Renal plasma flow (RPF) was sig-
nificantly higher in the first group (768.2 30 and 650.7 16; P
0.01) where 15 out of the 56 subjects had an RPF above the upper
limit of the controls, whereas the corresponding filtration frac-
tion was below the lower value of the controls. PRA was slightly
lower in the first group (0.74 0.07 and 0.96 0.12; NS). These
results (a higher RPF without differences in cardiac index) show
a relationship between familiality for hypertension and renal
function in young, still normotensive subjects. The analogies
with the results obtained in MHS rats will be discussed.
Renal ammonium production and amino acid (AA) uptake in
acute metabolic acidosis (AMA). G. Garibouo, C. Robaudo, G.
Dc Ferrari, and A. Tizianello. Istituto Scientifico di Iviedicina
Interna, Servizio di Nefrologia, Università di Genova, Italy. Uri-
nary ammonium excretion increases in AMA. It is not known
whether renal ammonium production is enhanced and which pre-
cursors of ammonium are utilized by the kidney in the same con-
dition. Renal ammonium production (urinary ammonium plus
ammonium added to the renal veins) and the extraction of AA by
the kidney were evaluated in 6 normal subjects with ammonium
chloride AMA and in 8 normal subjects as controls. Blood sam-
ples were simultaneously collected from renal veins and a pe-
ripheral artery. AA were measured in triplicate on whole blood
with an AA analyzer. Ammonium was measured with the phe-
nol-hypochlorite method. Results are given in micromoles per
minute. In AMA, renal ammonium production rose significantly
(62.3 7.1 vs. 38.8 4.3) whereas Gln, Pro, and citrulline were
extracted at control rates. In this condition, a significant extrac-
tion of Gly (11.2 0.7)and Orn (1.5 0.6) was observed. These
data show that a 61% increase in renal ammonium production
may be justified by a more complete utilization of Gin nitrogen
groups and that other AA, such as Gly and perhaps Orn, may
play an important role in renal ammoniagenesis.
Renal and intrarenal hemodynamics in patients with liver cir-
rhosis before and after portal-systemic shunt. A. Gatta, C. Mer-
kel, R. Zuin, L. Milani, U. Baccaglini, M. Grassetto, G. P.
Spina Patologia Medica dn Patologia Chirurgica, University of
Padua, Italy. Portal hypertension is considered a pathogenetic
factor involved in the onset of functional renal failure in liver
cirrhosis. A number of experimental data support this hypothe-
sis, but from a clinical point of view there is no evidence that it is
so. Renal and intrarenal blood flow was determined in 8 patients
with liver cirrhosis before and 20 to 30 days after portal-systemic
shunt by means of 133-Xe washout method. Additionally, in 15
cirrhotic patients, PAH clearance and inulin clearance were de-
termined immediately before and 20 days after shunt. In the 8
patients studied by means of 133-Xe washout, portal pressure fell
from 39.6 3.8 to 21.1 6.1 cm H20; mean renal blood flow
before surgery was 1.65 0.44 and after surgery 2.10 0.55 ml!
g/min; cortical blood flow before surgery was 2.78 0.53 and
after surgery 2.94 0.88 mug/mm. In the 15 patients studied with
the renal clearances, portal pressure fell from 37.3 5.1 to 23.1
4.9cm H20; PAH clearance before surgery was 419 201 and
after surgery 418 211 mI/mm; inulin clearance was 108 37
and 100 30 mI/mm, respectively. It is concluded that portal
hypertension alone is not sufficient to cause the renal hemo-
dynamic alterations found in patients with liver cirrhosis.
Histologic, ultrastructural, and immunohistologic study of gb-
merulonephritis (GN) associated with essential mixed cryogbobuli-
nemia (EMC). E. Imbasciati, A. Tarantino, G. Banfi, L. Guerra,
M. J. Mihatsch and H. U. Zollinger. Divisione di Nefrologia,
Ospedale Policlinico, Milano, Italy, and Inst it utfuer Pat hologie,
Base!, Switzerland. An LM study of 22 cases of GN associated
with EMC showed minimal glomerular lesions in 2, mesangial
proliferative ON in 7, and membranoproliferative GN in 13 pa-
tients. Additional findings were present: intraluminal hyaline
thrombi in 12 cases, increased mononuclear leucotyes in 9, and
necrotizing arteriolar lesions in 5. An EM study, performed in 9
cases, showed in 7 highly specific findings. A variable amount of
deposits with crystalloid structure was observed in sub-
endothelial spaces, between the cells and free in the lumina,
sometimes forming large thrombi. The same material was also
detected in peritubular capillaries and arteriolar walls. Areas of
amorphous translucent material, beside crystalloid aggregates
were frequently seen. Monocytes containing large droplets of
highly electron-dense material without evident structure was
found in 5 cases. An EM study of serum cryoprecipitate showed
the same crystalloid structure of the glomerular deposits. Immu-
nofluorescence, performed in 15 cases, showed IgG, 1gM, C3,
and more rarely IgA, Clq, C4, and fibrin on capillary loops. In-
traluminal thrombi when present contained only immunoglobu-
lins. Conclusion. Glomerular lesions of EMC are characterized
by specific abnormalities which suggest peculiar pathogenetic
mechanisms.
Preliminary results of the effect of dialytic treatment in chronic
schizophrenia. S. Lamperi, S. Carozzi, D. Trasforini, C. Loep,
G. Roccatagliata, and M. Maffini. Division of Nephrology, Gen-
eral Hospital, Dept. of Neurology, University of Genoa, Genoa,
Italy. Five nonnephropathic schizophrenic males (mean age, 24
years), with chronic course of the illness lasting 4 to 9 years,
have been treated with periodical dialysis. Frequent hospital-
izations and different drug therapy and/or electronarcosis were
ineffective. Four patients have been submitted to 16 dialyses,
twice a week, for 2 hours, first with Detoxyl filters and after with
Travenol HD filters. One subject discontinued dialysis after the
sixth session because of worsening of psychic symptoms. Psy-
chodrug therapy has been stopped during treatment except for
some hypnotic drugs. The effect of the treatment when evaluated
clinically or by the Overall and Corham scales and the Wais test
showed a complete remission of the psychotic symptoms in two
cases, a marked improvement in one case, and a worsening in
two cases. The usual blood and urine tests were normal; the en-
dogenous middle molecule assay—high pretreatment values—re-
verted to normal after dialysis in two patients who had the best
results. These partial and preliminary data suggest the dialytic
treatment is of some help in chronic schizophrenia and is free
from adverse reactions.
Unbalanced prostaglandin synthesis in uremic patients. M. Liv-
io, A. Cavenaghi, A. Schieppati, G. de Gaetano, G. Mecca, and
G. Remuzzi. Division of Nephrology, Ospedali Riuniti, Bergamo
and Istituto di Ricerche Farmacologiche Mario Negri", Milan,
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Italy. Venous tissues from 50 patients with renal failure (5 acute
and 45 chronic) generated significantly higher PGI2-like (platelet
aggregation inhibitory) activity than venous tissues from 30 nor-
mal subjects. The longer the bleeding times, the higher the values
for P012-like activity found in these patients. Both bleeding
times and PGI2-like activity values returned to normal in 3 acute
uremic patients on restoration of their renal function. Two addi-
tional patients with acute renal failure and greatly prolonged
bleeding times were under aspirin treatment at the moment of
this study: venous specimens from neither of them generated
measurable amounts of PGI2-like material. Malondialdehyde for-
mation in platelets from 12 patients with chronic renal failure and
prolonged bleeding times was significantly lower than in the
platelets from II controls. The defect was evident with each of
the three stimuli used, i.e. collagen, arachidonic acid, and throm-
bin. It is concluded that prostaglandin metabolism in platelets
and in the vessel wall from uremic patients is impaired in dif-
ferent ways.
Is prostacyclin a defence mechanism against thrombotic occlu-
sions of vacular accesses for hemodialysis? M. Livio, E. Poletti, A.
Cavenaghi, D. Marchesi, G. Mecca, and G. Remuzzi. Nephrol-
ogy Division, Ospedali Riuniti, Bergamo, and istituto di Ricer-
che Farmacologiche Mario Negri, Milan, italy. Regular hemo-
dialysis is frequently complicated by thrombotic occlusion of the
vascular access. Age, sex, hematocrit value, and the primary
kidney disease are some of the factors influencing the incidence
of this complication. Local factors may also be of great impor-
tance. We have measured prostacyclin (PGI2)-like activity in
venous specimens obtained bioptically at the moment of the in-
stitution of internal vascular access in 10 patients with chronic
renal failure.Occlusion of the vascular access occurred within 8
months in 5 patients. Distribution of age, sex, hematocrit value,
and previous renal disease was similar in this group as compared
to the 5 patients whose accesses did not present thrombotic epi-
sodes during the same observation period. PG12-like activity was
within the normal range in all 5 patients with thrombotic epi-
sodes, whereas it was significantly increased in 4 out of 5 patients
without thrombotic complications (P = 0.05). Mean PG12-like
activity in the two groups was 1.00 0.36 and 8.47 3.81, re-
spectively. It is suggested that increased PG12 activity may con-
stitute an effective defence mechanism against the development
of thrombotic occlusion in patients undergoing regular hemo-
dialysis.
Glomerulonephritis of congenital syphilis: Evidence of specific
antibody in glomerular deposits. A. Losito, F. Massi-Benedetti,
E. Bucciarelli, and M. Lato. Divisione emodialisi, Osp. Policli-
nico Perugia: C/mica Pediatrica Univ. Perugia; and 1st Anato-
mia ed Istologia Patol. Univ. Perugia. A case of congenital syphi-
us is described in which glomerulonephritis was the only mani-
festation of the disease. The renal biopsy showed mesangial and
subepithelial deposits in the glomeruli. The low levels of early
serum complement components indicated an activation of classi-
cal pathway. Furthermore, the patient's serum exhibited a C3-
splitting ability in vitro. The isolated cryoglobulins, of IgG-IgM
type, showed a specific antitreponemal activity. The elution
study on renal tissue confirmed the presence of antitreponemal
antibody in glomerular deposits. This evidences the direct re-
sponsibility of immune complexes in the pathogenesis of glomer-
ulonephritis of congenital syphilis.
Kidney tissue, blood, and urine librinolytic activity decrease: A
primary factor or secondary manifestation of renal damage? G.
Mangiarotti, M. Dogliani, A. Pacitti, C. Giachino, P. E. Ne-
biolo, A. Thea, and A. Vercellone. Cattedra di Nefrologia Mcdi-
ca, Divisioni di Nefrologia e Dialisi dell'Ospedale Maggiore di
San Giovanni Battista e della Cittd di Torino, Italy. The kidney
occupies a special place in the physiology of the fibrinolytic sys-
tem, because it can release plasminogen activator into blood and
it is also a source of urokinase, the plasminogen activator present
in urine. Although several evidences suggest a significant role
played by glomerular fibrin deposition in certain forms of renal
diseases, the mechanisms by which fibrin is deposited or re-
moved from glomeruli have not been defined. Experimental data
strongly suggest a possible significance of a loss of fibrinolytic
activity in the pathogenesis of microthrombotic processes in the
kidney. We adopted a fibrin slide technique to study the presence
and localization of fibrinolytic activity of 95 renal biopsy speci-
mens: normal (2), acute glomerulonephritis (GN) (5), mesangial
proliferative GN (7), minimal change GN (3), membranous GN
(6), membranoproliferative GN (10), focal sclerosing GN (6),
end—stage GN (5), Berger's disease (22), lupus nephritis (13), He-
noch-Schoelein disease (2), Goodpasture's syndrome (2), vascu-
lar disease (8), pyelonephritis (2), amyloidosis (1), and pan-
arteritis (1). Urinary urokinase levels were measured using As-
tnip fibrin plate methods in 136 specimens of a variety of renal
diseases: 15 acute renal failure, 14 chronic renal failure (end—
stage and in hemodialysis), 7 functioning renal homografts and
100 different glomerulonephritis and vascular diseases. Blood fi-
brinolytic activity was measured by Fearly test (diluted-clot-lysis
time) in 146 patients: 10 with acute renal failure, 43 with chronic
renal failure, and 83 with different GN. Correlations were made
with glomerular antifibrinogen-like immunofluorescent staining
and FR antigens urinary levels. On the basis of these studies,
three data could be outlined and discussed: (I) Renal tissue,
blood, and urine simultaneously lost fibrinolytic activity in acute
renal failure and rose as clinical improvement of renal disease
occurred. (2) A dramatic acceleration in blood fibrinolytic activi-
ty was found in lupus (together with burr poikilocytosis) not al-
ways related to increased fibrinolysis in the renal tissue and
urine. (3) Little fibrinolytic activity was found in only I out of 7
patients with functioning grafts, who underwent nephrectomy
for chronic rejection 3 weeks following control.
Role of vascular endothelium in the bleeding tendency of uremic
patients. D. Marchesi, M. Livio, A. Canenaghi, T. Bertani, G.
Mecca, and G. Remuzzi. Nephrology Division, Ospedali Riuniti
Bergamo and Mario Negri Research institute, Milan, italy. The
role of vascular factors in the bleeding tendency of uremic pa-
tients is poorly understood. We have studied three major factors
of the hemostatic system normally present in vascular tissues:
factor Vill-related protein (FVIII), plasminogen activator (PA),
and prostacyclin (PGI2). No differences in FVIII were found
from 13 patients and 11 normal subjects when endothelium was
studied by immunofluorescence. PA measured by a histochemi-
cal technique was equally present on the vascular intima of both
7 patients and 7 controls. In contrast, PGI2, a vascular prosta-
glandin with potent antiaggregatory and vasodilatory activity,
was significantly increased in venous specimens (from 60 pa-
tients with either acute or chronic uremia as compared with 30
controls). It was normalized in patients with acute renal failure
when renal function was restored. These data suggest that PGI2
could play an important role in the disturbed hemostatis of ure-
mic patients.
Hemodialysis and hemoperfusion in the treatment of paraquat
and diquat poisoning. F. Mastrangelo, T. Lopez, S. Rizzelli, G.
Manisco, C. Corlianô, and L. Alfonso. Service of Nephrology
and Dialysis, Hospital V. Fazzi, Lecce, italy. The ingestion of
paraquat and diquat is generally lethal, because of the serious
effects on the respiratory tract, kidney, liver, and heart. The in-
toxication is characterized by a protracted persistence of the
substance in the bloodstream even for 5 to 8 days after ingestion.
We have examined the effect of hemodialysis and hemoperfusion
in the depuration of the poison in vitro and in vivo (5 patients).
The clearances observed with different dialyzers and hemo-
perfusion, the behavior of serum concentrations, the differences
of depuration between aqueous and plasmatic solutions are stud-
ied. Results. Hemoperfusion is more effective than hemo-
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dialysis, which in its turn shows a higher depurative efficiency
than peritoneal dialysis and forced diuresis. Generally, the plas-
matic concentration of paraquat does not affect the values of
clearances, whereas it can affect the saturation capacity of the
hemoperfusor. Clinically, the comparison between patients
treated with depurative techniques (5 patients) and patients
treated with traditional therapy (12 subjects) enables us to be in
favor of the use of hemodialysis and particularly of hemo-
perfusion. We have standardized a therapeutic protocol in case
of poisoning, which considers an early and long-term depurative
treatment.
Actuarial survival in adult primitive glomerulonephritis and its
relationship with histologic patterns, clinical course, and therapy.
V. Mioli and L. Forastieri e Coil. Cattedra Nefrologia Medica,
Università di Ancona. Centro E/aborazione Dali, Osp. Reg.
Umberto I" An, Italy. Two hundred fifty-four adult patients
with primitive glomerulonephritis have been studied in a 5-year
follow-up, in which 305 renal biopsy examinations with light im-
munofluorescent and (in some cases) electron microscopy have
been carried out. For each histologic type, data concerning sex,
age, clinical course, laboratory findings, and evolution have been
processed. Actuarial rates of recovery, improvement, hyper-
tension onset and worsening have been calculated by the Cutler-
Ederer method either in relation to the presence or absence of a
nephrotic syndrome or in relation to different therapeutic sched-
ules. Recovery at 1 year did not exceed 30% of all cases—irre-
spective of therapy—and prognosis is worse if a nephrotic syn-
drome is present at the onset.
Beta cell activity in uremia: Insulin and C peptide secretion after
i.v. glucose load. G. Panzetta, G. Mioii, L. Cristinelli, R.
Maiorca, A. Albertini, C. Rigosa, R. Valentini, andG. Giustina.
Division of Nephrology, Horm Laboratory, II Med Div. Spedali
Civili di Brescia, Italy. To evaluate the secretory activity of the
betacells in uremics (24 patients; serum creatinine, 7.9 3.6 ug/
dl), we recorded simultaneous peripheral changes of immuno-
reactive C peptide (CP) and total insulin (I) after i.'. glucose load
(Conard's K). Controls were 9 healthy subjects. Since I and CP
are secreted in equimolecular rates and CP has a longer half-life,
which minimizes the influence of the renal failure on C peptide's
early rise, the CP increment at 3 mm (zCP) was considered a
reliable index of I secretion. Results were:
C.K Basal I
> 1 nmoleslliter
I
3 mm
BasalCP
nmoies/iiter
ACP
3 mm
9N 100% 0.04 0.02 0.18 0.06 0.65 0.1 0.74 0.2
24U 37% 0.05 0.03 0.31 0.15 2.09 0.5 0.70 0.3
P NS <0.01 <0.01 NS
Severe uremic patients (s.creat., 10.2 1.7 mllmin) had an early
CP secretion lower than controls (0.49 0.29 nmoles/liter, P <
0.02). In uremic patients, as a whole, an inverse correlation (P <
0.01) was found between creatinine and early CP secretion. The
low increase in plasma CP at 3 mm in severe uremic patients
suggests a reduced beta-cell secretion after glucose load. The re-
duction is a function of the renal impairment. The higher I con-
centration can probably be explained by its longer half-life in ure-
mic patients.
Immunologic reactivity in chronic renal failure. D. Plavijanic,
V. Molnar, B. Vita/c, and B. Benkovic. Ospedale Generate, Cen-
tro Emodialisi e di Nefrologia, Istituto 'Ruder Boskovic", Za-
greb. Patients are often affected by bacterial infections. We have
controlled whether immunologic reactivity of these patients was
compromised, because this tendency to infections could be re-
lated to an immunologic deficiency. Immunologic reactivity has
been studied by means of the following in vivo and in vitro tests:
delayed cutaneous PPD reactivity, peripheral leukocytes migra-
tion inhibition test in presence of PPD, PHA stimulation lympho-
cyte test, and T and B percentage count in peripheral blood. Pos-
itive cutaneous tests to PPD were present only in the minority of
uremic patients. Lymphocytes of uremic patients tested with AB
serum obtained from healthy donors normally responded to PHA
stimulation test. Stimulation lymphocyte test carried out on au-
tologous plasma was deeply depressed in all uremic patients ex-
amined. Peripheral blood lymphocytes were significantly de-
creased, whereas T and B cell percentage remained unchanged in
uremic patients. Conclusion. The impaired immunoreactivity of
uremic patients could result from both, i.e. peripheral lympho-
cyte decrease or serum toxic substances. Furthermore, hemo-
dialysis proved effective—at least on a temporary basis—in re-
moving from the blood either toxic substances or those sub-
stances which are responsible for the impaired immunoreactivity
of uremic patients.
Oxalosis in uremic stage. A. Poggi, E. Bonu cci, D. Brancaccio,
S. Sisca, L. Scu/lica, G. Romeo, C. Ciccarelli, S. Parlongo, and
Q. Maggiore. Centro Fisiologia Clinica CNR Divisione Nefrolo-
gica, Ospedali RiunitiReggio Calabria, Italy. The study is based
on the observations of three uremic dialyzed patients with pri-
mary oxalosis. A peculiar involvement of retinas, seldom report-
ed previously, has been observed in two patients, consisting of a
widespread deposition of bright crystals in peripapillar and peri-
macular regions. Such a finding appears to be a rather specific
feature of oxalosis in the uremic stage as it was never observed in
90 control dialyzed uremics showing various degrees of second-
ary hyperparathyroidism. The bone biopsy provided in every in-
stance the clue to diagnosis. By light and electron microscopic
examination of osseous tissue, we gained insight into the respec-
tive contribution of crystal deposition and uremic dystrophy to
the development of the severe osteopathy in this condition. This
evaluation took advantage of the unique opportunity provided by
one patient who had been surgically treated for his secondary
hyperparathyroidism 5 years before. This patient presented the
most severe and rapidly progressive osseous lesions despite per-
sistently normal levels of PTH. Some features of the osseous
radiologic picture, useful for differentiating this condition from
uremic osteodystrophy, are underlined.
Acute renal failure and microangiopathic hemolytic anemia: A
new therapeutic approach possibly related to prostaglandin metab-
olism. G. Remuzzi, R. Misiani, M. Livio, A. Cavenaghi, D.
Marchesi, G. de Gaetano, M. B. Donati, and G. Mecca. Ne-
phrology Division, Ospedali Riuniti, Bergamo, and Islituto Ri-
cerche Farmaco/ogiche l'Iario Negri, Milano, Italy. Micro-
angiopathic hemolytic anemia (MHA) is one of the main signs of
several syndromes characterized by vascular endothelial dam-
age, hemolysis, trombocytopenia, neurologic complications, and
often renal failure. Pathologic examination and cx juvantibus
therapeutic criteria suggest a crucial role of intravascular platelet
aggregates in these syndromes. Lately, treatment with plasma
exchange has been successfully attempted: this procedure would
act either by removing a toxic factor from plasma or by supplying
a lacking plasma component. Data will be reported supporting
the latter hypothesis. Three patients with MHA and acute renal
failure were successfully treated with plasma infusions. The
lacking plasma factor is possibly a mediator of prostaglandin syn-
thesis. Indeed, plasma from these three patients was unable to
stimulate the synthesis of vascular prostacyclin, a potent endog-
enous inhibitor of platelet aggregation. Such an activity was
present in normal plasma and in patients' plasma following in-
fusion.
Lymphocyte subpopulations in minimal change nephropathy.
M. Sasdelli, L. Cagnoli, C. Rovinetti, E. Beltrandi, L. Catizone,
and P. Zucchelli. Divisione di Nefrologia e Dialisi, Ospedale
Malpighi, Bologna, Italy. Lymphocyte cell-surface markers (E
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and EAC rosettes) and functional markers (mitogenic response
to PHA, ConA, and PWM) examined in autologous and homolo-
gous serum, were studied in 7 patients with minimal change ne-
phropathy (MCN) and nephrotic syndrome (NS) and in 10 pa-
tients with MCN on remission compared to 10 patients with
membranous glomerulonephritis (MG) and 30 normal controls.
The response to PHA and PWM of MCN with NS was within
normal range. The response to ConA and the percentage of E
rosettes were markedly reduced. Similar lymphocyte abnormal-
ities were not observed in MCN on remission and in MG with
NS. In 4 patients, studied at the onset of nephrotic syndrome and
subsequently on remission, the functional and numerical lym-
phocyte deficit disappeared. In 4 out of 5 patients with MGN and
NS serum inhibitory factors were detected. It is suggested that in
MCN a deficit of T cells exists, but the question remains whether
this deficit results from the presence of humoral inhibitory fac-
tors or from an intrinsic disorder of T lymphocytes.
Effects of 1-Sar,8-Ile-angiotensin II in malignant human hyper-
tension. P. T. Scarpelli, R. Sproviero, C. Corti, E. Chegai, P.
Menniti, L. Lamanna. Is! ituto di Clinica Medica e Terapia Mcdi-
ca (R), Università di Firenze, Italy. A selective antagonist of
angiotensin II (Sart-11e8-AII) has been infused iv. at a rate of 0.5
gIkg/min over a period of 30 mm in 6 patients affected by accel-
erated or malignant hypertension. In two patients with high PRA
levels, a fall either in systolic or in diastolic blood pressure oc-
curred. A fall of blood pressure, even though at a lesser degree,
has been obtained also in 2 of the 3 patients with normal levels of
PRA. In the third patient, the All blockade provoked a little in-
crease in systolic blood pressure and no effects on diastolic pres-
sure. These results demonstrate that the renin-angiotensin sys-
tem plays a role in maintaining high blood pressure levels in hu-
man malignant hypertension. However, the variable levels of
PRA of these patients and the lack of a uniform response to the
removal of All's effect suggest that other different mechanisms
may be involved in the course of the disease or some phases of it.
Problem of circulating immune complexes (IC) in the pathogene-
sis of primary glomerulonephritis (GN). F. P. Schena, A. Pas-
tore, S. Romito, V. Losuriello, E. Larata, and A. Tedesco. 2nd
Clinica Medica, Medical School, University of Ban, Italy. Re-
cent data on primary GN have shown that IC play an important
role in its pathogenesis; nevertheless, their presence during the
acute phase of the disease is not always associated with the acti-
vation of the complement system (C). To clarify these correla-
tions, we carried out a comparative study between two groups of
patients with different diseases: 135 with GN (100 with primary
GN and 35 with secondary GN) and 85 with neoplasms affecting
different organs. The serial measurement of IC and C was done
during the course of GN and/or after the surgical removal of the
tumor. The following methods were used: (a) '25l-Clq binding
test for the detection of IC; (b) immunological and hemolytic
dosages for the C (CH5O, Clq, C4, C2, C3, C3PA); (c) isolation
and characterization of IC. The results obtained in GN were:
high serum levels of IC in the acute phase of the disease, tran-
sient and/or intermittent appearance of IC that was associated
(not always) with hypocomplementemia. In patients with solid
neoplasms, high levels of IC and C, which decreased after the
surgical removal of the tumor, were observed. The identification
of the IC components isolated in some cases showed IgG, 1gM,
Clq, C4, and C3 in primary GN, whereas IgG and 1gM were pres-
ent in neoplasms. This comparative study suggests the presence
of two IC types in human pathology that have a different behav-
ior regarding the C system: an activating effect in GN and a
blocking action in neoplasms. The rare correlations between C
and IC in GN could be explained by this twofold aspect of IC
which is related to the different composition of IC. Therefore,
the activity phase in GN could be evaluated better by measuring
IC, rather than by assaying C.
Plasma catecholamine levels and chronic hypotension in hemo-
dialysis patients. G. Verzetti, G. B. Picottj, C. Ravazzani, A.
Cavagnino, F. Fortina, M. De Leo, A. Baroni, G. Airoldi, and C.
Schweiger. Divisione di Nefrologia Ospedale Civile, Borgoma-
nero (No), and Istitulo di Farmacologia Universitá di Milano,
italy. Nineteen patients undergoing hemodialysis, 6 with chronic
hypotension (mean blood pressure, 90 mm Hg) and 13 normoten-
sive were studied. The plasma catecholamine concentration (epi-
nephrine, norepinephrin, dopamine) before and after combined
stimulation test with hypoglycemia and standing were deter-
mined by a radioenzymatic assay. The results were compared
with those from 9 normal subjects. In patients with chronic hypo-
tension, the basal mean values of norepinephrine (NE) are signif-
icantly higher than those found in normal and normotensive sub-
jects. Both in hypotensive and in normotensive patients the in-
crease in plasma catecholamines, after stimulation test, is similar
to that obtained in normal subjects: epinephrine and NE in-
crease, whereas dopamine does not change. The elevated levels
of circulating NE found in regular hemodialysis patients, related
by some authors to a disturbance in metabolism and to a dimin-
ished or abolished renal clearance of NE, seem rather an ex-
pression of a sympathetic response to the decrease of blood pres-
sure. In patients with chronic hypotension, who are considered
to be suffering from sympathetic hyporeactivity, the stimulation
test has not demonstrated an increase in plasma catecholamine
levels lower than that found in hemodialyzed patients with nor-
mal blood pressure.
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Effect of chronic metabolic acidosis on the metabolism of alanine
in isolated dog kidney tubule. G. Baverel, M. Bonnard, M. Foris-
sier, M. Pellet. Laboratoire de Physiologic Rénale et Métabo-
lique, Faculté de Médecine Alexis Carrel, Lyon, France.
The metabolism of alanjne was studied in isolated cortical tu-
bules obtained from normal (N = 7) and acidotic (N = 6) dogs.
The tubules were incubated at 37° C for 60 mm in 4 ml of Krebs-
Henseleit medium (pH, 7.40), with 1 mM L-alanine as substrate.
The production of glutamate, ammonia, glucose, lactate, and
pyruvate, as well as alanine utilization, were determined. Values
are given as mean SEM. They are expressed in micromoles per
gram dry wt of tubules per 60 mm. Alanine utilization was: con-
